Abstract
Acute bacterial meningitis continues to be a significant health concern, with a fatality rate of more than 30% in some studies. Although the face of bacterial meningitis has changed substantially over the past 15 years, this disease still causes significant mortality (particularly in underdeveloped countries) and neurological sequelae. Our understanding of the pathophysiology of bacterial meningitis continues to develop. Our understanding of the mechanisms of neuronal injury now includes the concept that many of the pathological changes are only secondary to the infection and that the human immune system contributes to the majority of the neuronal death. A complicated series of interactions among immune, vascular and central nervous system cells, cytokines and chemokines, matrix metalloproteinases and free radical molecules are ultimately responsible for many bacterial meningitis changes. We hope that a complete understanding of these processes will ultimately lead to better diagnostic techniques and improved treatments.
Similar content being viewed by others
References and Recommended Reading
Bryan JP, et al.: Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis 1990, 12:128–135.
Gold R: Epidemiology of bacterial meningitis. Infect Dis Clin North Am 1999, 13(suppl 3):515–525. Update on the changing epidemiology of bacterial meningitis
Schuchat A, et al.: Bacterial Meningitis in the United States in 1995. N Engl J Med 1997, 337(suppl 14):970–976. Demonstrates the virtual elimination of Hib meningitis
Leib SL, Tauber MG: Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 1999, 13(suppl_3):527–548. Excellent review
Irazuzta JE, et al.: Hypothermia decreases excitatory neurotransmitter release in bacterial meningitis in rabbits. Brain Res 1999, 847(suppl 1):143–148. Suggests that hypothermia may decrease the amount of CNS damage associated with bacterial meningitis
Shen EY, et al.: Excitatory and inhibitory amino acid levels in the cerebrospinal fluids of children with neurological disorders (English abstract). Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1999, 40(suppl 2):65–69.
Kastenbauer S, Koedel U, Pfister HW: Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 1999, 180(suppl 4):1164–1170.
Paul R, et al.: Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998, 44(suppl 4):592–600.
Azeh I, et al.: Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci Lett 1998, 256(suppl 3):127–30.
Kieseier BC, et al.: Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 1999, 122(Pt 8):1579–1587. Analyzes the spectrum of different MMPs involved in experimental menigococcal meningitis.
Matsuura E, et al.: Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci 2000, 173(suppl 1):45–52.
Lee MA, et al.: Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study [see comments]. Brain 1999, 122(Pt 2):191–197.
Leib S, et al.: Combined inhibition of tumor-necrosis-factor-alpha converting enzyme and matrix-metalloproteinases by BB1101 attenuates disease, mortality and brain damage in experimental bacterial meningitis. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C.: Am Soc Microbiol; 1999.
Tauber M, Kim Y, Leib S: Neuronal Injury in Meningitis. In Defense of the Brain: Current Concepts in the Immunopathogenesis of Clinical Aspects of CNS Infections. Edited by Peterson PK Peterson, Remington JS. CITY:North Point Press; 1997:124–143. Another excellent review of the pathology and pathogenesis of bacterial meningitis
Granert IC, et al.: Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit. Infect Immun 1999, 67(suppl 5):2071–2074.
Freyer D, et al.: Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol 1999, 163(suppl 8):4308–4314.
Bogdan I, et al.: Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis 1997, 176(suppl 3):693–697. TNF-alpha’s role in neuronal apoptosis.
Ohga S, et al.: Cerebrospinal fluid cytokine levels and dexamethasone therapy in bacterial meningitis. J Infect 1999, 39(suppl 1):55–60.
Lopez-Cortes LF, et al.: Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients [see comments]. Crit Care Med 2000, 28(suppl 1):215–219.
Quagliarello VJ, et al.: Recombinant human interleukin-1 induces meningitis and blood-brain injury in the rat: characterization and comparison with tumor necrosis factor. J Clin Invest 1991, 87:1360–1366.
van Deuren M, et al.: The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 1997, 90(suppl 3):1101–1108.
Lopez-Cortes LF, et al.: Interleukin 6 in cerebrospinal fluid of patients with meningitis is not a useful diagnostic marker in the differential diagnosis of meningitis. Ann Clin Biochem 1997, 34(Pt 2):165–169.
Gendrel D, et al.: Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999, 18(suppl 10):875–881.
Rusconi F, et al.: Interleukin 6 activity in infants and children with bacterial meningitis. Pediatr Infect Dis J 1991, 10:117–121.
Paris MM, et al.: The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis. J Infect Dis 1997, 176(suppl 5):1239–1246.
Leib SL, et al.: Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest 1996, 98(suppl 11):2632–2639.
Clemens JA, et al.: Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res Mol Brain Res 1997, 48(suppl 2):187–196.
Mayer AM, et al.: Escherichia coli lipopolysaccharide potentiation and inhibition of rat neonatal microglia superoxide anion generation: correlation with prior lactic dehydrogenase, nitric oxide, tumor necrosis factor-alpha, thromboxane B2, and metalloprotease release. Shock 1999, 11(suppl 3):180–186.
Bernatowicz A, et al.: Pneumococci induce primary rat astrocytes cultures to release nitric oxide. In 34th ICAAC. Orlando: PUBLISHER; 1991.
Uysal G, et al.: Cerebrospinal fluid nitric oxide levels in childhood bacterial meningitis. Scand J Infect Dis 1999, 31(suppl 5):518–520.
Dawson TM, Dawson VL, Snyder SH: A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992, 32:297–311.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nathan, B.R., Scheld, W.M. New advances in the pathogenesis and pathophysiology of bacterial meningitis. Curr Infect Dis Rep 2, 332–336 (2000). https://doi.org/10.1007/s11908-000-0012-1
Issue Date:
DOI: https://doi.org/10.1007/s11908-000-0012-1